18th April 2022 | Pharma Updates

Hyderabad is becoming a popular destination for pharmaceutical investments

Over the last year, Hyderabad has become one of the preferred destinations for global pharma biotech investments, attracting approximately 7,500 crore of investment.

In mice, India's 'warm' vaccine candidate effective against Delta and Omicron variants

According to a mouse study, a heat-stable COVID-19 vaccine that is being developed in India has generated a strong antibody response against coronavirus variants such as Delta and Omicron.

Lanka sends out an SOS for pharmaceutical supplies, but drugmakers wary

The Sri Lankan agency in charge of drug procurement has requested that the Indian body representing pharmaceutical exporters “sensitise” its members to the importance of ensuring medical supplies to the crisis-hit island nation.

Sinopharm and Sinovac Covid vaccine candidates for Omicron cleared for clinical trials

COVID-19 vaccine candidates targeting the Omicron variant were approved for clinical trials in Hong Kong by a Sinopharm subsidiary and Sinovac Biotech (SVA.O).

Nuclear technology applications bringing a path for personalised theranostics

Nuclear medicine has an advantage over all other diagnostic techniques because it detects disease based on metabolic changes rather than changes in organ structure.

WHO checking up on children in UK who have hepatitis of unknown origin

Britain initially reported 10 cases of severe acute hepatitis in Scotland to WHO on April 5, before reporting a total of 74 cases across the country three days later.

Regeneron's bid for full approval of COVID-19 drug impeded as FDA delays its review

REGEN-COV, Regeneron’s COVID-19 antibody combination, has been sidelined in the US due to omicron, and the drug has hit a stumbling block in its quest for full FDA approval.